[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Dexlansoprazole API Market Growth 2023-2029

March 2023 | 94 pages | ID: G78470151F34EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Dexlansoprazole is used to heal and maintain healing of erosive esophagitis and to treat heartburn associated with gastroesophageal reflux disease (GERD). It lasts longer than lansoprazole, to which it is chemically related, and needs to be taken less often. There is no good evidence that it works better than other PPIs.

LPI (LP Information)' newest research report, the “Dexlansoprazole API Industry Forecast” looks at past sales and reviews total world Dexlansoprazole API sales in 2022, providing a comprehensive analysis by region and market sector of projected Dexlansoprazole API sales for 2023 through 2029. With Dexlansoprazole API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dexlansoprazole API industry.

This Insight Report provides a comprehensive analysis of the global Dexlansoprazole API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dexlansoprazole API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Dexlansoprazole API market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dexlansoprazole API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dexlansoprazole API.

The global Dexlansoprazole API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Dexlansoprazole API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Dexlansoprazole API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Dexlansoprazole API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Dexlansoprazole API players cover Piramal Enterprises Limited, Metrochem API Private Limited, Zhejiang Hengkang Pharmaceutical, Lupin Ltd, Dipharma, Optimus Pharma P Limited and Orchid Chemicals & Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Dexlansoprazole API market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Purity?98%
  • Purity<98%
Segmentation by application
  • Dexlansoprazole Capsules
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Piramal Enterprises Limited
  • Metrochem API Private Limited
  • Zhejiang Hengkang Pharmaceutical
  • Lupin Ltd
  • Dipharma
  • Optimus Pharma P Limited
  • Orchid Chemicals & Pharmaceuticals
Key Questions Addressed in this Report

What is the 10-year outlook for the global Dexlansoprazole API market?

What factors are driving Dexlansoprazole API market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Dexlansoprazole API market opportunities vary by end market size?

How does Dexlansoprazole API break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Dexlansoprazole API Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Dexlansoprazole API by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Dexlansoprazole API by Country/Region, 2018, 2022 & 2029
2.2 Dexlansoprazole API Segment by Type
  2.2.1 Purity?98%
  2.2.2 Purity<98%
2.3 Dexlansoprazole API Sales by Type
  2.3.1 Global Dexlansoprazole API Sales Market Share by Type (2018-2023)
  2.3.2 Global Dexlansoprazole API Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Dexlansoprazole API Sale Price by Type (2018-2023)
2.4 Dexlansoprazole API Segment by Application
  2.4.1 Dexlansoprazole Capsules
  2.4.2 Others
2.5 Dexlansoprazole API Sales by Application
  2.5.1 Global Dexlansoprazole API Sale Market Share by Application (2018-2023)
  2.5.2 Global Dexlansoprazole API Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Dexlansoprazole API Sale Price by Application (2018-2023)

3 GLOBAL DEXLANSOPRAZOLE API BY COMPANY

3.1 Global Dexlansoprazole API Breakdown Data by Company
  3.1.1 Global Dexlansoprazole API Annual Sales by Company (2018-2023)
  3.1.2 Global Dexlansoprazole API Sales Market Share by Company (2018-2023)
3.2 Global Dexlansoprazole API Annual Revenue by Company (2018-2023)
  3.2.1 Global Dexlansoprazole API Revenue by Company (2018-2023)
  3.2.2 Global Dexlansoprazole API Revenue Market Share by Company (2018-2023)
3.3 Global Dexlansoprazole API Sale Price by Company
3.4 Key Manufacturers Dexlansoprazole API Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Dexlansoprazole API Product Location Distribution
  3.4.2 Players Dexlansoprazole API Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR DEXLANSOPRAZOLE API BY GEOGRAPHIC REGION

4.1 World Historic Dexlansoprazole API Market Size by Geographic Region (2018-2023)
  4.1.1 Global Dexlansoprazole API Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Dexlansoprazole API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Dexlansoprazole API Market Size by Country/Region (2018-2023)
  4.2.1 Global Dexlansoprazole API Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Dexlansoprazole API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Dexlansoprazole API Sales Growth
4.4 APAC Dexlansoprazole API Sales Growth
4.5 Europe Dexlansoprazole API Sales Growth
4.6 Middle East & Africa Dexlansoprazole API Sales Growth

5 AMERICAS

5.1 Americas Dexlansoprazole API Sales by Country
  5.1.1 Americas Dexlansoprazole API Sales by Country (2018-2023)
  5.1.2 Americas Dexlansoprazole API Revenue by Country (2018-2023)
5.2 Americas Dexlansoprazole API Sales by Type
5.3 Americas Dexlansoprazole API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Dexlansoprazole API Sales by Region
  6.1.1 APAC Dexlansoprazole API Sales by Region (2018-2023)
  6.1.2 APAC Dexlansoprazole API Revenue by Region (2018-2023)
6.2 APAC Dexlansoprazole API Sales by Type
6.3 APAC Dexlansoprazole API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Dexlansoprazole API by Country
  7.1.1 Europe Dexlansoprazole API Sales by Country (2018-2023)
  7.1.2 Europe Dexlansoprazole API Revenue by Country (2018-2023)
7.2 Europe Dexlansoprazole API Sales by Type
7.3 Europe Dexlansoprazole API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Dexlansoprazole API by Country
  8.1.1 Middle East & Africa Dexlansoprazole API Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Dexlansoprazole API Revenue by Country (2018-2023)
8.2 Middle East & Africa Dexlansoprazole API Sales by Type
8.3 Middle East & Africa Dexlansoprazole API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dexlansoprazole API
10.3 Manufacturing Process Analysis of Dexlansoprazole API
10.4 Industry Chain Structure of Dexlansoprazole API

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Dexlansoprazole API Distributors
11.3 Dexlansoprazole API Customer

12 WORLD FORECAST REVIEW FOR DEXLANSOPRAZOLE API BY GEOGRAPHIC REGION

12.1 Global Dexlansoprazole API Market Size Forecast by Region
  12.1.1 Global Dexlansoprazole API Forecast by Region (2024-2029)
  12.1.2 Global Dexlansoprazole API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Dexlansoprazole API Forecast by Type
12.7 Global Dexlansoprazole API Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Piramal Enterprises Limited
  13.1.1 Piramal Enterprises Limited Company Information
  13.1.2 Piramal Enterprises Limited Dexlansoprazole API Product Portfolios and Specifications
  13.1.3 Piramal Enterprises Limited Dexlansoprazole API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Piramal Enterprises Limited Main Business Overview
  13.1.5 Piramal Enterprises Limited Latest Developments
13.2 Metrochem API Private Limited
  13.2.1 Metrochem API Private Limited Company Information
  13.2.2 Metrochem API Private Limited Dexlansoprazole API Product Portfolios and Specifications
  13.2.3 Metrochem API Private Limited Dexlansoprazole API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Metrochem API Private Limited Main Business Overview
  13.2.5 Metrochem API Private Limited Latest Developments
13.3 Zhejiang Hengkang Pharmaceutical
  13.3.1 Zhejiang Hengkang Pharmaceutical Company Information
  13.3.2 Zhejiang Hengkang Pharmaceutical Dexlansoprazole API Product Portfolios and Specifications
  13.3.3 Zhejiang Hengkang Pharmaceutical Dexlansoprazole API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Zhejiang Hengkang Pharmaceutical Main Business Overview
  13.3.5 Zhejiang Hengkang Pharmaceutical Latest Developments
13.4 Lupin Ltd
  13.4.1 Lupin Ltd Company Information
  13.4.2 Lupin Ltd Dexlansoprazole API Product Portfolios and Specifications
  13.4.3 Lupin Ltd Dexlansoprazole API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Lupin Ltd Main Business Overview
  13.4.5 Lupin Ltd Latest Developments
13.5 Dipharma
  13.5.1 Dipharma Company Information
  13.5.2 Dipharma Dexlansoprazole API Product Portfolios and Specifications
  13.5.3 Dipharma Dexlansoprazole API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Dipharma Main Business Overview
  13.5.5 Dipharma Latest Developments
13.6 Optimus Pharma P Limited
  13.6.1 Optimus Pharma P Limited Company Information
  13.6.2 Optimus Pharma P Limited Dexlansoprazole API Product Portfolios and Specifications
  13.6.3 Optimus Pharma P Limited Dexlansoprazole API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Optimus Pharma P Limited Main Business Overview
  13.6.5 Optimus Pharma P Limited Latest Developments
13.7 Orchid Chemicals & Pharmaceuticals
  13.7.1 Orchid Chemicals & Pharmaceuticals Company Information
  13.7.2 Orchid Chemicals & Pharmaceuticals Dexlansoprazole API Product Portfolios and Specifications
  13.7.3 Orchid Chemicals & Pharmaceuticals Dexlansoprazole API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Orchid Chemicals & Pharmaceuticals Main Business Overview
  13.7.5 Orchid Chemicals & Pharmaceuticals Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Dexlansoprazole API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Dexlansoprazole API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity?98%
Table 4. Major Players of Purity<98%
Table 5. Global Dexlansoprazole API Sales by Type (2018-2023) & (Ton)
Table 6. Global Dexlansoprazole API Sales Market Share by Type (2018-2023)
Table 7. Global Dexlansoprazole API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Dexlansoprazole API Revenue Market Share by Type (2018-2023)
Table 9. Global Dexlansoprazole API Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Dexlansoprazole API Sales by Application (2018-2023) & (Ton)
Table 11. Global Dexlansoprazole API Sales Market Share by Application (2018-2023)
Table 12. Global Dexlansoprazole API Revenue by Application (2018-2023)
Table 13. Global Dexlansoprazole API Revenue Market Share by Application (2018-2023)
Table 14. Global Dexlansoprazole API Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Dexlansoprazole API Sales by Company (2018-2023) & (Ton)
Table 16. Global Dexlansoprazole API Sales Market Share by Company (2018-2023)
Table 17. Global Dexlansoprazole API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Dexlansoprazole API Revenue Market Share by Company (2018-2023)
Table 19. Global Dexlansoprazole API Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Dexlansoprazole API Producing Area Distribution and Sales Area
Table 21. Players Dexlansoprazole API Products Offered
Table 22. Dexlansoprazole API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Dexlansoprazole API Sales by Geographic Region (2018-2023) & (Ton)
Table 26. Global Dexlansoprazole API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Dexlansoprazole API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Dexlansoprazole API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Dexlansoprazole API Sales by Country/Region (2018-2023) & (Ton)
Table 30. Global Dexlansoprazole API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Dexlansoprazole API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Dexlansoprazole API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Dexlansoprazole API Sales by Country (2018-2023) & (Ton)
Table 34. Americas Dexlansoprazole API Sales Market Share by Country (2018-2023)
Table 35. Americas Dexlansoprazole API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Dexlansoprazole API Revenue Market Share by Country (2018-2023)
Table 37. Americas Dexlansoprazole API Sales by Type (2018-2023) & (Ton)
Table 38. Americas Dexlansoprazole API Sales by Application (2018-2023) & (Ton)
Table 39. APAC Dexlansoprazole API Sales by Region (2018-2023) & (Ton)
Table 40. APAC Dexlansoprazole API Sales Market Share by Region (2018-2023)
Table 41. APAC Dexlansoprazole API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Dexlansoprazole API Revenue Market Share by Region (2018-2023)
Table 43. APAC Dexlansoprazole API Sales by Type (2018-2023) & (Ton)
Table 44. APAC Dexlansoprazole API Sales by Application (2018-2023) & (Ton)
Table 45. Europe Dexlansoprazole API Sales by Country (2018-2023) & (Ton)
Table 46. Europe Dexlansoprazole API Sales Market Share by Country (2018-2023)
Table 47. Europe Dexlansoprazole API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Dexlansoprazole API Revenue Market Share by Country (2018-2023)
Table 49. Europe Dexlansoprazole API Sales by Type (2018-2023) & (Ton)
Table 50. Europe Dexlansoprazole API Sales by Application (2018-2023) & (Ton)
Table 51. Middle East & Africa Dexlansoprazole API Sales by Country (2018-2023) & (Ton)
Table 52. Middle East & Africa Dexlansoprazole API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Dexlansoprazole API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Dexlansoprazole API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Dexlansoprazole API Sales by Type (2018-2023) & (Ton)
Table 56. Middle East & Africa Dexlansoprazole API Sales by Application (2018-2023) & (Ton)
Table 57. Key Market Drivers & Growth Opportunities of Dexlansoprazole API
Table 58. Key Market Challenges & Risks of Dexlansoprazole API
Table 59. Key Industry Trends of Dexlansoprazole API
Table 60. Dexlansoprazole API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Dexlansoprazole API Distributors List
Table 63. Dexlansoprazole API Customer List
Table 64. Global Dexlansoprazole API Sales Forecast by Region (2024-2029) & (Ton)
Table 65. Global Dexlansoprazole API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Dexlansoprazole API Sales Forecast by Country (2024-2029) & (Ton)
Table 67. Americas Dexlansoprazole API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Dexlansoprazole API Sales Forecast by Region (2024-2029) & (Ton)
Table 69. APAC Dexlansoprazole API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Dexlansoprazole API Sales Forecast by Country (2024-2029) & (Ton)
Table 71. Europe Dexlansoprazole API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Dexlansoprazole API Sales Forecast by Country (2024-2029) & (Ton)
Table 73. Middle East & Africa Dexlansoprazole API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Dexlansoprazole API Sales Forecast by Type (2024-2029) & (Ton)
Table 75. Global Dexlansoprazole API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Dexlansoprazole API Sales Forecast by Application (2024-2029) & (Ton)
Table 77. Global Dexlansoprazole API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Piramal Enterprises Limited Basic Information, Dexlansoprazole API Manufacturing Base, Sales Area and Its Competitors
Table 79. Piramal Enterprises Limited Dexlansoprazole API Product Portfolios and Specifications
Table 80. Piramal Enterprises Limited Dexlansoprazole API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Piramal Enterprises Limited Main Business
Table 82. Piramal Enterprises Limited Latest Developments
Table 83. Metrochem API Private Limited Basic Information, Dexlansoprazole API Manufacturing Base, Sales Area and Its Competitors
Table 84. Metrochem API Private Limited Dexlansoprazole API Product Portfolios and Specifications
Table 85. Metrochem API Private Limited Dexlansoprazole API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Metrochem API Private Limited Main Business
Table 87. Metrochem API Private Limited Latest Developments
Table 88. Zhejiang Hengkang Pharmaceutical Basic Information, Dexlansoprazole API Manufacturing Base, Sales Area and Its Competitors
Table 89. Zhejiang Hengkang Pharmaceutical Dexlansoprazole API Product Portfolios and Specifications
Table 90. Zhejiang Hengkang Pharmaceutical Dexlansoprazole API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Zhejiang Hengkang Pharmaceutical Main Business
Table 92. Zhejiang Hengkang Pharmaceutical Latest Developments
Table 93. Lupin Ltd Basic Information, Dexlansoprazole API Manufacturing Base, Sales Area and Its Competitors
Table 94. Lupin Ltd Dexlansoprazole API Product Portfolios and Specifications
Table 95. Lupin Ltd Dexlansoprazole API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Lupin Ltd Main Business
Table 97. Lupin Ltd Latest Developments
Table 98. Dipharma Basic Information, Dexlansoprazole API Manufacturing Base, Sales Area and Its Competitors
Table 99. Dipharma Dexlansoprazole API Product Portfolios and Specifications
Table 100. Dipharma Dexlansoprazole API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Dipharma Main Business
Table 102. Dipharma Latest Developments
Table 103. Optimus Pharma P Limited Basic Information, Dexlansoprazole API Manufacturing Base, Sales Area and Its Competitors
Table 104. Optimus Pharma P Limited Dexlansoprazole API Product Portfolios and Specifications
Table 105. Optimus Pharma P Limited Dexlansoprazole API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Optimus Pharma P Limited Main Business
Table 107. Optimus Pharma P Limited Latest Developments
Table 108. Orchid Chemicals & Pharmaceuticals Basic Information, Dexlansoprazole API Manufacturing Base, Sales Area and Its Competitors
Table 109. Orchid Chemicals & Pharmaceuticals Dexlansoprazole API Product Portfolios and Specifications
Table 110. Orchid Chemicals & Pharmaceuticals Dexlansoprazole API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Orchid Chemicals & Pharmaceuticals Main Business
Table 112. Orchid Chemicals & Pharmaceuticals Latest Developments

LIST OF FIGURES

Figure 1. Picture of Dexlansoprazole API
Figure 2. Dexlansoprazole API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dexlansoprazole API Sales Growth Rate 2018-2029 (Ton)
Figure 7. Global Dexlansoprazole API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Dexlansoprazole API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity?98%
Figure 10. Product Picture of Purity<98%
Figure 11. Global Dexlansoprazole API Sales Market Share by Type in 2022
Figure 12. Global Dexlansoprazole API Revenue Market Share by Type (2018-2023)
Figure 13. Dexlansoprazole API Consumed in Dexlansoprazole Capsules
Figure 14. Global Dexlansoprazole API Market: Dexlansoprazole Capsules (2018-2023) & (Ton)
Figure 15. Dexlansoprazole API Consumed in Others
Figure 16. Global Dexlansoprazole API Market: Others (2018-2023) & (Ton)
Figure 17. Global Dexlansoprazole API Sales Market Share by Application (2022)
Figure 18. Global Dexlansoprazole API Revenue Market Share by Application in 2022
Figure 19. Dexlansoprazole API Sales Market by Company in 2022 (Ton)
Figure 20. Global Dexlansoprazole API Sales Market Share by Company in 2022
Figure 21. Dexlansoprazole API Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Dexlansoprazole API Revenue Market Share by Company in 2022
Figure 23. Global Dexlansoprazole API Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Dexlansoprazole API Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Dexlansoprazole API Sales 2018-2023 (Ton)
Figure 26. Americas Dexlansoprazole API Revenue 2018-2023 ($ Millions)
Figure 27. APAC Dexlansoprazole API Sales 2018-2023 (Ton)
Figure 28. APAC Dexlansoprazole API Revenue 2018-2023 ($ Millions)
Figure 29. Europe Dexlansoprazole API Sales 2018-2023 (Ton)
Figure 30. Europe Dexlansoprazole API Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Dexlansoprazole API Sales 2018-2023 (Ton)
Figure 32. Middle East & Africa Dexlansoprazole API Revenue 2018-2023 ($ Millions)
Figure 33. Americas Dexlansoprazole API Sales Market Share by Country in 2022
Figure 34. Americas Dexlansoprazole API Revenue Market Share by Country in 2022
Figure 35. Americas Dexlansoprazole API Sales Market Share by Type (2018-2023)
Figure 36. Americas Dexlansoprazole API Sales Market Share by Application (2018-2023)
Figure 37. United States Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Dexlansoprazole API Sales Market Share by Region in 2022
Figure 42. APAC Dexlansoprazole API Revenue Market Share by Regions in 2022
Figure 43. APAC Dexlansoprazole API Sales Market Share by Type (2018-2023)
Figure 44. APAC Dexlansoprazole API Sales Market Share by Application (2018-2023)
Figure 45. China Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Dexlansoprazole API Sales Market Share by Country in 2022
Figure 53. Europe Dexlansoprazole API Revenue Market Share by Country in 2022
Figure 54. Europe Dexlansoprazole API Sales Market Share by Type (2018-2023)
Figure 55. Europe Dexlansoprazole API Sales Market Share by Application (2018-2023)
Figure 56. Germany Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Dexlansoprazole API Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Dexlansoprazole API Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Dexlansoprazole API Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Dexlansoprazole API Sales Market Share by Application (2018-2023)
Figure 65. Egypt Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Dexlansoprazole API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Dexlansoprazole API in 2022
Figure 71. Manufacturing Process Analysis of Dexlansoprazole API
Figure 72. Industry Chain Structure of Dexlansoprazole API
Figure 73. Channels of Distribution
Figure 74. Global Dexlansoprazole API Sales Market Forecast by Region (2024-2029)
Figure 75. Global Dexlansoprazole API Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Dexlansoprazole API Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Dexlansoprazole API Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Dexlansoprazole API Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Dexlansoprazole API Revenue Market Share Forecast by Application (2024-2029)


More Publications